닫기
Article Search
닫기

Journal of Cancer Prevention

Review

Journal of Cancer Prevention 2015; 20(2): 92-96

Published online June 30, 2015

https://doi.org/10.15430/JCP.2015.20.2.92

© Korean Society of Cancer Prevention

Anticancer Effect of Lycopene in Gastric Carcinogenesis

Mi Jung Kim, and Hyeyoung Kim

Department of Food and Nutrition, Brain Korea 21 PLUS Project, College of Human Ecology, Yonsei University, Seoul, Korea

Correspondence to :
Hyeyoung Kim, Department of Food and Nutrition, Brain Korea 21 PLUS Project, College of Human Ecology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Korea Tel: +82-2-2123-3125, Fax: +82-2-364-5781, E-mail: kim626@yonsei.ac.kr, ORCID: Hyeyoung Kim, http://orcid.org/0000-0002-7019-917X

Received: May 18, 2015; Revised: June 20, 2015; Accepted: June 20, 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Go to

Gastric cancer ranks as the most common cancer and the second leading cause of cancer-related death in the world. Risk factors of gastric carcinogenesis include oxidative stress, DNA damage, Helicobacter pylori infection, bad eating habits, and smoking. Since oxidative stress is related to DNA damage, smoking, and H. pylori infection, scavenging of reactive oxygen species may be beneficial for prevention of gastric carcinogenesis. Lycopene, one of the naturally occurring carotenoids, has unique structural and chemical features that contributes to a potent antioxidant activity. It shows a potential anticancer activity and reduces gastric cancer incidence. This review will summarize anticancer effect and mechanism of lycopene on gastric carcinogenesis based on the recent experimental and clinical studies.

Keywords: Anticancer effect, Lycopene, Gastric carcinogenesis

INTRODUCTION

Go to

Gastric cancer is one of the most common cancers in the world, following lung, breast and colorectal cancer.1?3 Risk factors of gastric cancer include poor diet, smoking, family history, inflammation, and Helicobacter pylori infection.4,5 Epidemiological studies have shown that diet including antioxidant nutrients plays an important role in prevention of cancer development.6,7 Especially, consumption of lycopene reduced risk of several cancers.8?10 However, compared to other cancers such as prostate cancer, anticancer effect of lycopene in gastric carcinogenesis has not been well studied. Lycopene is thought to be the active component in red fruits and vegetables such as tomatoes. In addition to its potential anticancer activity, lycopene supplementation decreased the occurrence of chronic diseases including type 2 diabetes, osteoporosis, and coronary heart disease.11 Since lycopene has 11 conjugated double bonds, it functions as the most potent antioxidant among carotenoids.12 Therefore, lycopene prevents the oxidative damage of DNA, lipids and proteins.13 Other potential mechanisms of lycopene include cell cycle arrest, modulation of immune function, and induction of apoptotic cell death.14 Lycopene also inhibited reactive oxygen species (ROS) production and decreased the phosphorylation of extracellular signal-regulated kinase (ERK), resulting in inhibition of cancer cell growth.6,15?17 Here, we review the anticancer effect and mechanism of lycopene in gastric carcinogenesis based on the recent advances in experimental and epidemiologic studies.

ANTIOXIDANT ENZYME ACTIVITIES

Go to

Oxidative stress-mediated DNA damage and tissue injury are related to cancer development.18,19 When the damaged cells divide, DNA duplication and cell metabolism become aberrant. Therefore, mutation is an important factor in carcinogenesis and oxidative damage could lead to carcinogenesis.20,21 Several studies reported that antioxidants inhibit oxidative damage and decrease abnormal cell division.22,23 Protective effect of antioxidants plays a critical role in prevention of cancer. Since gastrointestinal tract could easily be exposed to external and internal stimuli which produce ROS, the levels of antioxidants are especially important for preventing cellular damage. Antioxidants and antioxidant enzymes including glutathione (GSH), glutathione peroxidase (GPx), glutathione-S-transferase (GST) are involved in scavenging oxygen free radicals.24 GSH protects essential cellular components from ROS-mediated damage and regulates cell proliferation. Lycopene, compared to other carotenoids and antioxidants such as α-tocopherol and β-carotene, is a powerful antioxidant with a singlet oxygen quenching activity.25 Treatment of lycopene significantly reduced the extent of lipid peroxidation and enhanced the activities of GSH-dependent enzymes in gastric cancer rats.26 Lycopene reduced oxidative injury by stimulating levels and activities of GSH, GST, GPx enzymes in gastric cancer animals.27,28 These findings demonstrate that lycopene may have anticancer effect by increasing activities of antioxidant enzymes and reducing oxidative damage in gastric mucosa.

CELL PROLIFERATION AND APOPTOSIS

Go to

ERK signaling is involved in cell cycle checkpoints and mitosis. Therefore, ERK is considered as a major regulator of cell proliferation, apoptosis, and differentiation.29,30 Lycopene increased G0?G1 phase and decreased S phase in human gastric cancer HGC-27 cells.30 Lycopene inhibited phospholylation of ERK in gastric cancer cells as well as hepatocarcinoma cells.30,31 Yang et al.31 reported that enzymatic metabolite of lycopene, apo-8′-lycopena, suppressed protein expression of Rho small GTPases and inhibited focal adhesion kinase-mediated signaling pathway, such as ERK/p38 and phosphatidylinositol 3-kinase-Akt axis. These findings suggest that lycopene may contribute to anti-proliferative effects in gastric cancer cells by inhibiting activation of ERK and inducing cell cycle arrest.

Bcl-2 is considered as an important anti-apoptotic protein and regulates cell death.32 Bcl-2 inhibits apoptosis by reducing caspase activation such as caspase 3 and 8.33 Caspase 3, apoptosis-related cysteine peptidase, interacts with caspase 8. These proteins are involved in the programmed cell death induced by various stimuli.34 Apoptosis regulator Bax protein, a member of Bcl-2 family proteins, promotes apoptosis. As a pro-apoptotic protein, Bax induces release of cytochrome C and other pro-apoptotic factors from the mitochondria, leading to activation of caspases.35 Lycopene induced apoptosis in gastric cancer cells by decreasing Bcl-2 level and increasing the levels of Bax, caspase 3 and 8.33,36

A tumor suppressor gene p53 regulates the balance of cell proliferation and apoptosis. Several studies reported that p53 is overexpressed in gastric cancer.37,38 In gastric mucosa of rats exposed to cigarette smoke, p53 is overexpressed.39 Upon p53 is activated, p53 target gene such as p21, a cyclin-dependent kinase inhibitor, regulates cell cycle arrest in G1 and induces apoptosis.40 Lycopene supplementation prevented changes in p53 expression in gastric mucosa of ferrets.39 Therefore, lycopene may protect against the development of gastric cancer by inhibiting p53-dependent apoptosis and correcting the unbalance of apoptosis and cell proliferation.

HELICOBACTER PYLORI

Go to

Over half of the world’s population is colonized with H. pylori which is a gram-negative bacterium.41H. pylori infection linked to chronic gastritis, gastric ulcers, and gastric cancer. One of the toxic factors in the pathogenesis of H. pylori infection is ROS. Nuclear factor-κB (NF-κB) is activated by ROS in the infected cells. NF-κB activation leads to induction of TNF-α and chemokines in H. pylori-infected gastric epithelial cells. H. pylori-induced TNF-α and interleukin-6 could alter gastric epithelial cell adhesion and result in migration of mutated epithelial cells.42 TNF-α-inducing protein (Tipα) binds to nucleolin which is localized on the surface of gastric cancer cells.43 Interaction between Tipα and nucleolin causes a cancer-oriented microenvironment that increases the risk of gastric cancer. H. pylori also induces activation of ERK,44 which may be involved in hyper-proliferation of the infected cells.

H. pylori infection induced oxidative DNA damage.45,46 Jang et al.47 suggested that lycopene inhibited H. pylori-induced increases in ROS production and alterations in cell cycle distribution in gastric epithelial cells. In addition, H. pylori induced apoptosis with increased Bax and decreased Bcl-2 expression as well as cleavage of PARP-1.47 PARP-1, as an enzyme of DNA damage recovery, has a role in repair of single-stranded DNA breaks. These findings suggest that lycopene may be beneficial for treatment of H. pylori-associated gastric disorders even though clinical trial of lycopene as an adjunctive therapy for H. pylori eradication had no effect.48

EPIDEMIOLOGIC STUDIES

Go to

As described above, in vitro and in vivo studies show anticancer effect of lycopene in gastric carcinogenesis. Many countries have implemented the clinical study of lycopene as the main component of tomato and tomato products An inverse association between tomato intake and gastric cancer incidence has been reported in some epidemiologic studies.

In China, meta-analysis study supports the negative relationship between tomato consumption and risk of gastric cancer.49 The risk of gastric cancer was significantly reduced in people consuming high lycopene compared to low intake group.49 High serum levels of lycopene were significantly associated with reduced risk of developing gastric cancer.50 In Finland cohort study, lycopene treatment did not affect the risk of gastric cardia cancer but decreased the risk of gastric noncardia cancer by <33%.51 In a case-control study in Uruguay, tomato intake was strong inverse associations with stomach cancer development.52 In Japan, plasma levels of lycopene were lower in H. pylori-positive controls.53H. pylori infection has been found to decrease the absorption of many nutrients. In the experiment by Ito et al.54 serum levels of lycopene are associated with reduced risk of death from stomach cancer. They suggested that lycopene may be a promising biomarker to predict mortality from stomach cancer.

CONCLUSION

Go to

Lycopene from red fruits and vegetables has strong anticancer activity in gastric carcinogenesis. ROS have been implicated in the progression of several diseases including cancer. ROS cause severe cellular injury and promote tumor metastasis, angiogenesis, and invasion. As one of the most potent antioxidants, lycopene is effective in decreasing oxidative damage by activating antioxidant enzymes such as GSH, GPx and GST. Lycopene treatment inhibits cancer cell growth and induces apoptosis by suppressing ERK signaling pathway. Bcl-2 family and caspases are considered to be the most effective apoptotic regulators. Lycopene decreases Bcl-2 and increases Bax expression, which induce release of cytochrome C from mitochondria, leading to apoptosis. Lycopene treatment inhibits gastric cancer cell proliferation by increasing cell cycle arrest in G0?G1 phase. Moreover, lycopene prevents changes in p53 overexpression in gastric mucosa exposed to cigarette smoke. H. pylori infection is a high risk of gastric cancer. Lycopene inhibits H. pylori-induced increases in ROS levels and DNA damage in gastric epithelial cells. Korea is a high H. pylori prevalence and high gastric cancer incidence country. Since H. pylori infection rate in children is higher in Korea than other countries, consumption of red fruits and vegetables is recommended especially to the children to prevent H. pylori-associated gastric carcinogenesis.

Based on the studies, we propose a mechanism by which lycopene exerts protective effect against oxidative stress-mediated gastric carcinogenesis (Fig. 1). Smoking, inflammation, and H. pylori infection induce oxidative stress which leads to DNA damage, ERK activation and p53 overexpression, decreased activities of antioxidant enzymes (GSH, GST, GPx) as well as impaired immune function. Low activities of antioxidant enzymes may decrease immune function of gastric mucosa. ERK activation and p53 overexpression induce cell cycle disturbances and inhibition of apoptosis as well as hyper-proliferation, resulting in gastric carcinogenesis. Poor diet, bad eating habits, and family history may be risk factors to induce DNA damage and cell cycle disturbances by affecting intrinsic factors or producing ROS or oncogenic factors. Lycopene scavenges ROS and stimulates activities of antioxidant enzymes, which protects gastric mucosa against oxidative stress-induced ERK activation, p53 induction, cell cycle disturbances, and impaired immune function. Therefore, supplementation of lycopene or consumption of lycopene-containing fruits and vegetables may prevent oxidative stress-mediated gastric carcinogenesis.

Figures

Go to
Fig. 1. A schematic overview of the protective effect of lycopene against gastric carcinogenesis. Smoking, inflammation, and Helicobacter pylori infection induce oxidative stress which leads to DNA damage, ERK activation and p53 overexpression, decreased activities of antioxidant enzymes (GSH, GST, GPx) as well as impaired immune function. Low activities of antioxidant enzymes may decrease immune function of gastric mucosa. ERK activation and p53 overexpression induce cell cycle disturbances and inhibition of apoptosis as well as hyper-proliferation, resulting in gastric carcinogenesis. Poor diet, bad eating habits, and family history may be risk factors to induce DNA damage and cell cycle disturbances by affecting intrinsic factors or producing reactive oxygen species or oncogenic factors. Lycopene scavenges reactive oxygen species and stimulates activities of antioxidant enzymes, which protects gastric mucosa against oxidative stress-induced ERK activation, p53 induction, cell cycle disturbances, and impaired immune function. Therefore, lycopene may prevent oxidative stress-mediated gastric carcinogenesis. ERK, extracellular signal-regulated kinase; GSH, glutathione; GST, glutathione-S-transferase; GPx, glutathione peroxidase.

References

Go to
  1. Persson, C, Sasazuki, S, Inoue, M, Kurahashi, N, Iwasaki, M, and Miura, T (2008). Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: a nested case-control study. Carcinogenesis. 29, 1042-8.
    Pubmed CrossRef
  2. Tsugane, S, and Sasazuki, S (2007). Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 10, 75-83.
    Pubmed CrossRef
  3. Crew, KD, and Neugut, AI (2006). Epidemiology of gastric cancer. World J Gastroenterol. 12, 354-62.
    Pubmed KoreaMed
  4. Gonz?lez, CA, Pera, G, Agudo, A, Palli, D, Krogh, V, and Vineis, P (2003). Smoking and the risk of gastric cancer in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 107, 629-34.
    Pubmed CrossRef
  5. Uemura, N, Okamoto, S, Yamamoto, S, Matsumura, N, Yamaguchi, S, and Yamakido, M (2001). Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 345, 784-9.
    Pubmed CrossRef
  6. Palozza, P, Colangelo, M, Simone, R, Catalano, A, Boninsegna, A, and Lanza, P (2010). Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcinogenesis. 31, 1813-21.
    Pubmed CrossRef
  7. Liu, C, and Russell, RM (2008). Nutrition and gastric cancer risk: an update. Nutr Rev. 66, 237-49.
    Pubmed CrossRef
  8. Friedman, M, Levin, CE, Lee, SU, Kim, HJ, Lee, IS, and Byun, JO (2009). Tomatine-containing green tomato extracts inhibit growth of human breast, colon, liver, and stomach cancer cells. J Agric Food Chem. 57, 5727-33.
    Pubmed CrossRef
  9. Tang, FY, Cho, HJ, Pai, MH, and Chen, YH (2009). Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells. J Nutr Biochem. 20, 426-34.
    CrossRef
  10. Teodoro, AJ, Oliveira, FL, Martins, NB, Maia Gde, A, Martucci, RB, and Borojevic, R (2012). Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell Int. 12, 36.
    Pubmed KoreaMed CrossRef
  11. Salman, H, Bergman, M, Djaldetti, M, and Bessler, H (2007). Lycopene affects proliferation and apoptosis of four malignant cell lines. Biomed Pharmacother. 61, 366-9.
    Pubmed CrossRef
  12. Stahl, W, and Sies, H (1996). Lycopene: a biologically important carotenoid for humans?. Arch Biochem Biophys. 336, 1-9.
    Pubmed CrossRef
  13. Palozza, P, Simone, R, Catalano, A, Boninsegna, A, B?hm, V, and Fr?hlich, K (2010). Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J Nutr Biochem. 21, 34-46.
    CrossRef
  14. Rao, AV, Ray, MR, and Rao, LG (2006). Lycopene. Adv Food Nutr Res. 51, 99-164.
    Pubmed CrossRef
  15. Agarwal, S, and Rao, AV (2000). Tomato lycopene and its role in human health and chronic diseases. CMAJ. 163, 739-44.
    Pubmed KoreaMed
  16. Qu, M, Zhou, Z, Chen, C, Li, M, Pei, L, and Chu, F (2011). Lycopene protects against trimethyltin-induced neurotoxicity in primary cultured rat hippocampal neurons by inhibiting the mitochondrial apoptotic pathway. Neurochem Int. 59, 1095-103.
    Pubmed CrossRef
  17. Rao, LG, Mackinnon, ES, Josse, RG, Murray, TM, Strauss, A, and Rao, AV (2007). Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women. Osteoporos Int. 18, 109-15.
    CrossRef
  18. Li, X, Fang, P, Mai, J, Choi, ET, Wang, H, and Yang, XF (2013). Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J Hematol Oncol. 6, 19.
    Pubmed KoreaMed CrossRef
  19. Smith, KS, Yadav, VK, Pedersen, BS, Shaknovich, R, Geraci, MW, and Pollard, KS (2015). Signatures of accelerated somatic evolution in gene promoters in multiple cancer types. Nucleic Acids Res. 43, 5307-17.
    Pubmed KoreaMed CrossRef
  20. Sena, LA, and Chandel, NS (2012). Physiological roles of mitochondrial reactive oxygen species. Mol Cell. 48, 158-67.
    Pubmed KoreaMed CrossRef
  21. Halliwell, B (2007). Oxidative stress and cancer: have we moved forward?. Biochem J. 401, 1-11.
    CrossRef
  22. Pashkow, FJ (2011). Oxidative stress and inflammation in heart disease: Do antioxidants have a role in treatment and/or prevention?. Int J Inflam. 2011, 514623.
    Pubmed KoreaMed CrossRef
  23. Ames, BN, Shigenaga, MK, and Gold, LS (1993). DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis. Environ Health Perspect. 101, 35-44.
    Pubmed KoreaMed CrossRef
  24. Banerjee, BD, Seth, V, Bhattacharya, A, Pasha, ST, and Chakraborty, AK (1999). Biochemical effects of some pesticides on lipid peroxidation and free-radical scavengers. Toxicol Lett. 107, 33-47.
    Pubmed CrossRef
  25. Di Mascio, P, Kaiser, S, and Sies, H (1989). Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys. 274, 532-8.
    Pubmed CrossRef
  26. Velmurugan, B, Bhuvaneswari, V, and Nagini, S (2002). Antiperoxidative effects of lycopene during N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis. Fitoterapia. 73, 604-11.
    Pubmed CrossRef
  27. Luo, C, and Wu, XG (2011). Lycopene enhances antioxidant enzyme activities and immunity function in N-methyl-N′-nitro-N-nitrosoguanidine-enduced gastric cancer rats. Int J Mol Sci. 12, 3340-51.
    CrossRef
  28. Velmurugan, B, Bhuvaneswari, V, Burra, UK, and Nagini, S (2002). Prevention of N-methyl-N′-nitro-N-nitrosoguanidine and saturated sodium chloride-induced gastric carcinogenesis in Wistar rats by lycopene. Eur J Cancer Prev. 11, 19-26.
    Pubmed CrossRef
  29. Kohno, M, and Pouyssegur, J (2006). Targeting the ERK signaling pathway in cancer therapy. Ann Med. 38, 200-11.
    Pubmed CrossRef
  30. Zhang, B, and Gu, Y (2014). Low expression of ERK signaling pathway affecting proliferation, cell cycle arrest and apoptosis of human gastric HGC-27 cells line. Mol Biol Rep. 41, 3659-69.
    Pubmed CrossRef
  31. Yang, CM, Hu, TY, and Hu, ML (2012). Antimetastatic effects and mechanisms of apo-8′-lycopenal, an enzymatic metabolite of lycopene, against human hepatocarcinoma SK-Hep-1 cells. Nutr Cancer. 64, 274-85.
    CrossRef
  32. Yang, J, Liu, X, Bhalla, K, Kim, CN, Ibrado, AM, and Cai, J (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275, 1129-32.
    Pubmed CrossRef
  33. Velmurugan, B, Mani, A, and Nagini, S (2005). Combination of S-allylcysteine and lycopene induces apoptosis by modulating Bcl-2, Bax, Bim and caspases during experimental gastric carcinogenesis. Eur J Cancer Prev. 14, 387-93.
    Pubmed CrossRef
  34. Porter, AG, and J?nicke, RU (1999). Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6, 99-104.
    Pubmed CrossRef
  35. J?rgensmeier, JM, Xie, Z, Deveraux, Q, Ellerby, L, Bredesen, D, and Reed, JC (1998). Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci U S A. 95, 4997-5002.
    Pubmed KoreaMed CrossRef
  36. Khan, N, Afaq, F, and Mukhtar, H (2007). Apoptosis by dietary factors: the suicide solution for delaying cancer growth. Carcinogenesis. 28, 233-9.
    CrossRef
  37. Starzynska, T, Bromley, M, Ghosh, A, and Stern, PL (1992). Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer. 66, 558-62.
    Pubmed KoreaMed CrossRef
  38. Kakeji, Y, Korenaga, D, Tsujitani, S, Baba, H, Anai, H, and Maehara, Y (1993). Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes. Br J Cancer. 67, 589-93.
    Pubmed KoreaMed CrossRef
  39. Liu, C, Russell, RM, and Wang, XD (2006). Lycopene supplementation prevents smoke-induced changes in p53, p53 phosphorylation, cell proliferation, and apoptosis in the gastric mucosa of ferrets. J Nutr. 136, 106-11.
  40. Hastak, K, Agarwal, MK, Mukhtar, H, and Agarwal, ML (2005). Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J. 19, 789-91.
    Pubmed
  41. Parsonnet, J (1995). The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther. 9, 45-51.
    Pubmed
  42. Pathak, SK, Basu, S, Bhattacharyya, A, Pathak, S, Banerjee, A, and Basu, J (2006). TLR4-dependent NF-kappaB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages. J Immunol. 177, 7950-8.
    Pubmed CrossRef
  43. Suganuma, M, Watanabe, T, Yamaguchi, K, Takahashi, A, and Fujiki, H (2012). Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pylori. Cancer Lett. 322, 133-8.
    Pubmed CrossRef
  44. Zhu, Y, Chen, M, Gong, Y, Liu, Z, Li, A, and Kang, D (). Helicobacter pylori FKBP-type PPIase promotes gastric epithelial cell proliferation and anchorage-independent growth through activation of ERK-mediated mitogenic signaling pathway [published online ahead of print February 16, 2015]. FEMS Microbiol Lett.. , .
    CrossRef
  45. Sanderson, MJ, White, KL, Drake, IM, and Schorah, CJ (1997). Vitamin E and carotenoids in gastric biopsies: the relation to plasma concentrations in patients with and without Helicobacter pylori gastritis. Am J Clin Nutr. 65, 101-6.
    Pubmed
  46. Obst, B, Wagner, S, Sewing, KF, and Beil, W (2000). Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis. 21, 1111-5.
    Pubmed CrossRef
  47. Jang, SH, Lim, JW, Morio, T, and Kim, H (2012). Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells. Free Radic Biol Med. 52, 607-15.
    CrossRef
  48. Shidfar, F, Agah, S, Ekhlasi, G, Salehpour, A, and Ghourchian, S (2012). Lycopene an adjunctive therapy for Helicobacter pylori eradication: a quasi-control trial. J Complement Integr Med. 9, .
    Pubmed
  49. Yang, T, Yang, X, Wang, X, Wang, Y, and Song, Z (2013). The role of tomato products and lycopene in the prevention of gastric cancer: A meta-analysis of epidemiologic studies. Med Hypotheses. 80, 383-8.
    Pubmed CrossRef
  50. Yuan, JM, Ross, RK, Gao, YT, Qu, YH, Chu, XD, and Yu, MC (2004). Prediagnostic levels of serum micronutrients in relation to risk of gastric cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev. 13, 1772-80.
    Pubmed
  51. Nouraie, M, Pietinen, P, Kamangar, F, Dawsey, SM, Abnet, CC, and Albanes, D (2005). Fruits, vegetables, and antioxidants and risk of gastric cancer among male smokers. Cancer Epidemiol Biomarkers Prev. 14, 2087-92.
    Pubmed CrossRef
  52. De Stefani, E, Boffetta, P, Brennan, P, Deneo-Pellegrini, H, Carzoglio, JC, and Ronco, A (2000). Dietary carotenoids and risk of gastric cancer: A case-control study in Uruguay. Eur J Cancer Prev. 9, 329-34.
    Pubmed CrossRef
  53. Persson, C, Sasazuki, S, Inoue, M, Kurahashi, N, Iwasaki, M, and Miura, T (2008). Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: a nested case-control study. Carcinogenesis. 29, 1042-8.
    Pubmed CrossRef
  54. Ito, Y, Kurata, M, Hioki, R, Suzuki, K, Ochiai, J, and Aoki, K (2005). Cancer mortality and serum levels of carotenoids, retinol, and tocopherol: a population-based follow-up study of inhabitants of a rural area of Japan. Asian Pac J Cancer Prev. 6, 10-5.
    Pubmed

Article Tools

Metrics

Share this article on :

Related articles in JCP

Most KeyWord